Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Narcolepsy Marketed and Pipeline Drugs Report Overview
Narcolepsy is a chronic disorder that is mainly characterized by excessive daytime sleepiness and, in the majority of individuals, cataplexy—a sudden loss of muscle tone during wakefulness that is evoked by strong, usually positive, emotions. Patients with narcolepsy can also experience disturbed nighttime sleep, sleep paralysis, hypnagogic hallucinations, or hypnopompic hallucinations.
Narcolepsy marketed and pipeline drugs market research report report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, and late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for narcolepsy. The report also analyzes the clinical and commercial landscapes of narcolepsy, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Narcolepsy Marketed Drugs Report Overview
| Key Mechanisms of Action | · Transport Inhibitor
· Receptor Agonist · Receptor Antagonist |
| Key Routes of Administration | · Oral
· Injection |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Narcolepsy Pipeline Drugs Market Report Overview
| Key Mechanisms of Action | · Transport Inhibitor
· Receptor Agonist · Protein and Peptide Inhibitor · Receptor Antagonist |
| Key Routes of Administration | · Oral
· Injection · Inhalation |
| Key Molecule Types | · Small molecules
· Biologic |
Narcolepsy Marketed Drugs Segmentation by Mechanism of Action
The key mechanisms of action for Narcolepsy marketed drugs are transport inhibitor, receptor agonist, and receptor antagonist. The mechanism of action for most marketed drugs for Narcolepsy is transport inhibitor.
Narcolepsy Marketed Drugs Analysis by MoA, 2023 (%)
For more MoA insights into Narcolepsy marketed drugs, download a free report sample
Narcolepsy Marketed Drugs Segmentation by Routes of Administration
The key routes of administration for Narcolepsy marketed drugs are oral and injection. Out of all available marketed products used for narcolepsy (including generics and products used for symptomatic treatment), the majority are small molecule oral therapies.
Narcolepsy Marketed Drugs Analysis by RoA, 2023 (%)
For more RoA insights into the Narcolepsy marketed drugs, download a free report sample
Narcolepsy Pipeline Drugs Segmentation by Mechanisms of Action
The key mechanisms of action for Narcolepsy pipeline drugs are transport inhibitor, receptor agonist, protein and peptide inhibitor and receptor antagonist. Most of the Narcolepsy pipeline drugs are receptor agonist.
Narcolepsy Pipeline Drugs Analysis by MoA, 2023 (%)
For more MoA insights into the Narcolepsy pipeline drugs market, download a free report sample
Narcolepsy Pipeline Drugs Segmentation by Routes of Administration
The key routes of administration for Narcolepsy pipeline drugs are oral, injection, and inhalation. Of all the narcolepsy pipeline drugs, the oral route is the most common route of administration.
Narcolepsy Pipeline Drugs Analysis by RoA, 2023 (%)
For more RoA insights into the Narcolepsy pipeline drugs market, download a free report sample
Narcolepsy Drugs Segmentation by Molecule Type
Most of the pipeline drugs for Narcolepsy are small molecules. Biologic is the other significant molecule type in the pipeline drugs for Narcolepsy.
Narcolepsy Pipeline Drugs Analysis by Molecule Types, 2023 (%)
For more molecule type insights into the Narcolepsy pipeline drugs market, download a free report sample
Segments Covered in the Report
Narcolepsy Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Transport Inhibitor
- Receptor Agonist
- Receptor Antagonist
Narcolepsy Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Oral
- Injection
Narcolepsy Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Transport Inhibitor
- Receptor Agonist
- Protein and Peptide Inhibitor
- Receptor Antagonist
Narcolepsy Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Oral
- Injection
- Inhalation
Narcolepsy Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Small Molecules
- Biologic
Scope
GlobalData’s Narcolepsy: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include –
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Narcolepsy market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Narcolepsy market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently Asked Questions
The leading mechanisms of action for Narcolepsy marketed drugs is transport inhibitor.
The leading RoA for Narcolepsy marketed drugs is the oral route.
The leading mechanisms of action for Narcolepsy pipeline drugs is receptor agonist.
The leading RoA for Narcolepsy pipeline drugs is the oral route.
The leading molecule type in the Narcolepsy pipeline drugs market are small molecule.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Narcolepsy reports